GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hypha Labs FUNI · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Hypha Labs

From its filings with the US Securities and Exchange Commission

SEC filings

Hypha Labs is based in Las Vegas, Nevada and is incorporated in Nevada. Its shares trade on OTC under the ticker FUNI. The SEC classifies its business as testing laboratories. In the fiscal year to 30 September 2022, it reported revenue of $2.7m.

Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
23 Dec 2011
Employees
17
Head office
5940 S. RAINBOW BOULEVARD, LAS VEGAS, NV, 89118
Incorporated in
NV
Classification
Services-Testing Laboratories
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Mr. A. Stone DouglassChairman of the Board, President, Chief Executive Officer, Chief Financial Officer, Company Secretary, since 2021$57,400
  • Mr. Dennis HartmanIndependent Director, since 2019$134,800

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • DigiPath Labs, Inc. provides FDA-compliant cannabis testing with advanced equipment and processes.
  • Hypha Labs Inc. employs 17 full-time staff in Las Vegas, Nevada, supporting its testing and analytics services.
  • The company serves multiple segments including growers, dispensaries, and patients in the cannabis industry.

Weaknesses

  • DigiPath Labs, Inc. operates as a subsidiary under Hypha Labs Inc. with limited employee count.
  • The company's focus on cannabis testing restricts its market diversification opportunities.
  • Hypha Labs Inc. has no presence in international markets beyond the US.

Opportunities

  • Expanding cannabis testing services to new US states with legalized cannabis markets.
  • Growing demand for cannabis testing in the US market due to regulatory requirements.
  • Increasing partnerships with cannabis producers and dispensaries for expanded testing services.

Threats

  • Regulatory changes in the US cannabis industry could impact testing requirements.
  • Competition from other cannabis testing labs in Nevada and neighboring states.
  • Economic downturns affecting cannabis industry spending and testing demand.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.